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Abstract
The detrimental effects of hypoxic damage to central nervous system lead to energy
depletion, free radical formation, lipid peroxidation (LPO), and increased calcium.
Wehypothesizedthatinvitrotacrolimus(FK-506)andcyclosporineA(CsA)could
be protective against hypoxic damage in spinal cord. Dorsal columns were isolated
from the spinal cord of adult rats and injured by exposure to hypoxic condition for
1 h, and treated with FK-506 (0.1 μM) and CsA (0.1 μM). After injury, reperfusion
wascarriedoutfor2h.Tissueswerecollected,processedforbiochemicalassays,and
2,3,5-triphenyltetrazolium chloride (TTC) staining. Spinal cord hypoxia caused a
signiﬁcantdecrease(P <0.001)inmitochondrialATP(30.64%)andtissuereduced
glutathione(GSH)(60.14%)content.Conversely,asigniﬁcantincrease(P <0.001)
in tissue LPO level (57.77%) and myeloperoxidase (MPO) activity (461.24%) was
observed in hypoxic group. Mitochondrial swelling was also signiﬁcantly increased
inhypoxicgroup(90.0%).TreatmentwitheitherFK-506orCsAshowedthatsignif-
icant neuroprotective effects (P < 0.05–0.01) were measured in various parameters
in hypoxic groups. FK-506 and CsA treatment showed increase in ATP by 11.19%
and16.14%whileGSHcontentincreasedby66.46%and77.32%,respectively.Con-
versely, LPO content decreased by 18.97% and 24.06% and MPO level by 42.86%
and 18.66% after FK-506 and CsA treatment. Calcium uptake was also decreased
in mitochondria as exhibited by the increase in absorbance by 11.19% after FK-
506 treatment. TTC staining also showed increased viability after FK-506 and CsA
treatment. In conclusion, present study demonstrates the neuroprotective effect of
FK-506andCsAtreatmentagainstspinalcordhypoxiainduceddamageismediated
via their antioxidant actions.
Introduction
Spinal hypoxia leads to severe neurological damage and dys-
function.Thereisnocurrenteffectivetherapeutictreatment,
due to the limited capacity for axonal regeneration and myr-
iad inhibitory cues. Immediately after the primary damage,
other events cause secondary damages including energy de-
pletion, excitotoxicity, increased calcium inﬂux, free radical
formation,andlipidperoxidation(LPO;MobleyandAgrawal
2003). Basic strategy of treatment after spinal hypoxia is the
protectionoftheremaininghealthyspinalneuronsfromsec-
ondary damage that triggers multifarious degenerative pro-
cesses. Systemic and cellular level responses, which regulate
manyphysiologicalandpathologicalprocesses,aredisrupted
due to poor oxygen supply (Bunn and Poyton 1996). Mi-
tochondrial dysfunction as a result of poor oxygen supply
plays an important role in the pathophysiology of hypoxic
cell death (Kroemer et al. 1998). Mitochondrial dysfunction
leadstocellularoxidativestressandcelldeath.Preservingthe
mitochondrial integrity may be considered one of the basic
prophylactic cruxes for reducing the spinal cord injury.
Cyclosporin A (CsA, immunophillin) and FK-506
(Tacrolimus) are the most commonly used immunomodu-
latory agents. These immunosuppressants inhibit a calcium-
dependent phosphoserine–phosphothreonine protein
phosphatase, calcineurin, and thereby inhibit calcineurin-
mediated secondary neuronal damage (Sullivan et al. 2000;
Diaz–Ruiz et al. 2005). FK-506 is reported to exhibit both
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neuroprotective and neuroregenerative properties through
various mechanisms. Some mechanisms include the ability
to cross the blood brain barrier (BBB; Gold et al. 1997;
Steiner et al. 1997), inhibitory action against cytochrome c
release, antiinﬂammatory action (Furuichi et al. 2004), and
suppressing the death protein BAD (Wang et al. 1999). Shee-
han et al. (2006) reported the potentiating effect of CsA and
FK506 on neurite outgrowth as well as the protective effect
againstapoptoticcelldeathinahumanpostmitoticneuronal
cell line. Recently, it has been reported that pretreatment
with cyclosporin derivative NIM811 improves the function
of synaptic mitochondria by improving mitochondrial
respiratory control ratios in spinal cord contusion in rats
and by scavenging free radical generation in mitochondria
(McEwen et al. 2007).
Inthepresentstudy,wehaveinvestigatedtheneuroprotec-
tive effects of CsA and FK-506 in oxidative injury of spinal
cord white matter.
Material and Methods
Drugs and chemicals
FK-506 and CsA were purchased from Calbiochem. Calcium
chloride, ATP Kit, N-2-hydroxyethylpiperazine-N-2-ethane
sulfonic acid, sucrose, EDTA, Tris-HCl, ﬁcoll, percholl,
HEPES buffer, rotenone, antimycin, sulphosalicylic acid,
DTNB,butylatedhydroxyltoluene(BHT),ortho-phosphoric
acid(OPA),thiobarbituricacid(TBA),andortho-dianisidine
were procured from Sigma Aldrich Saint Louis, MO, USA.
Animals
Male Wistar rats (250–300 gm) were used. All animal pro-
cedures were approved by the Institutional Animal Care and
Use committee (IACUC) and University of Nebraska Med-
ical Center, NE, USA. Rats were housed at the animal care
facilityattheanimalhouseofUniversityofNebraskaMedical
Center, NE, USA.
Isolation of spinal cord
Rats were anesthetized with pentobarbital (40 mg/kg, i.p.).
When no ﬂexor withdrawal was seen in response to noxious
foot pinch, anesthesia was considered complete. Laminec-
tomywasperformedfromT4–T8region,andthenthespinal
cord was exposed and dissected out. Immediately, it was
placed in cold (4–7◦C) Ringer’s solution (124 mM NaCl,
5m MK C l ,1 . 2m MK 2HPO4,1 . 3m MM g S O 4,2m MC a C l 2,
20 mM glucose, and 26 mM NaHCO3, pH 7.4), dura matter
and the dorsal roots were excised in cold Ringer’s solution
bubbled continuously with 95% O2–5% CO2.
Experimental protocol
Animalsweredividedintofourgroups.GroupIwassham,in
whichtheharvestedspinalcordwasincubatedinoxygenated
(95%O2–5%CO2) Ringer’s solution at 37 ± 0.5◦Cf o r1h .
Group II was hypoxic group, in which the cord was incu-
bated in hypoxic(95%N2–5%CO2) Ringer’ssolution at 37±
0.5◦C for 1 h. Group III was FK-506-treated group (FK-506
+ Hypoxia), in which the spinal cord was incubated in hy-
poxic Ringer’s solution in the presence of FK-506 (0.1 μM)
at 37± 0.5◦C for 1 h. Group IV was treated with CsA (CsA +
Hypoxia), in which the spinal cord was incubated in hypoxic
Ringer’s solution with CsA (0.1 μM) at 37 ± 0.5◦Cf o r1h .
After hypoxia, reperfusion was carried out for 2 h with oxy-
genated (95%O2–5%CO2) Ringer’s solution. After the com-
pletion of all treatments, tissues from various groups were
processed for various biochemical estimations. Tissues were
homogenized (10%) in ice-cold homogenization medium (5
mMHEPESwith0.32Msucrose,1mMMgCl2,2mMEGT A,
and 0.1 mM PMSF). The homogenates were centrifuged at
10,000 ×g for 10 min at 4◦C and supernatant was collected
for LPO, reduced glutathione (GSH), and myeloperoxidase
(MPO) activity.
Isolation and puriﬁcation of mitochondria
Mitochondria were isolated and puriﬁed according to the
method of Rendon and Masmoudi (1985). Spinal cords were
ﬁnely minced brieﬂy and a 20% homogenate (w/v) was
made in isolation buffer (0.32 M sucrose, 1 mM EDTA K+,
10 mM Tris-HCl, pH 7.4). The homogenate was centrifuged
at 1100 ×g for 5 min. The resulting supernatant was again
centrifuged at 17,000 ×g for 10 min to yield the crude mi-
tochondrialpelletcontainingsynaptosomes(P2 fraction).P2
fraction was washed by resuspending in isolation buffer and
centrifuged at 17,000 ×g for 20 min. The pellet was resus-
pended in isolation buffer and manually homogenized. The
suspension was layered onto 7.5% ﬁcoll medium on 13% of
ﬁcollmediumandcentrifugedat100,000×g for30min.The
7.5% and 13% ﬁcoll media contained w/v ﬁcoll in isolation
buffer. Mitochondria were collected from the bottom of the
tube and washed again in isolation buffer and were stored in
–70◦C for further biochemical analysis.
ATP quantitation
The isolated mitochondria (1 mg/mL of protein) were re-
suspended in a reaction mixture containing 0.25 M sucrose,
1mMMgCl 2,10mMHEPES,and1mMEDTA.Thesuspen-
sionwascentrifugedat5000×g for10min.Thesupernatant
wasincubatedwithluciferin-luciferase(5mg/mL)andthebi-
oluminescencewasmeasuredbyFluostarOptimamicroplate
reader (BMG Labtech). The results were expressed as pmol
of ATP per mg protein.
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Measurement of mitochondrial swelling
Ca2+-inducedmitochondrialswellingofthedeenergizedmi-
tochondriawasdonebythemethodofHalestrapandDavid-
son (1990). Mitochondria (25 μgo fp r o t e i n )w e r ea d d e d
1.1 mL of isotonic buffer containing 150 mM KSCN, 5 mM
Tris, 0.5 μl rotenone/mL,and0.5 μgantimycin/mL(pH7.2)
at30◦C.SwellingwasinitiatedbyadditionofCa2+ (100μM)
to the cuvette and the absorbance was monitored for 5 min
at 540 nm. Change in absorbance was monitored as percent
change compared with the control values.
Lipid peroxidation (LPO)
LPO was determined by the procedure of Uchiyama and
Mihara (1978). Brieﬂy, 0.25 mL of tissue homogenate was
mixed with 25 μlo f1 0m MB H T .O P A( 3m Lo f1 %s o l u -
tion) and TBA (1 mL of 0.67% solution) were added and the
mixture was incubated at 90◦C for 45 min. The absorbance
w a sm e a s u r e da t5 3 5n m .T h er a t eo fL P Ow a se x p r e s s e da s
nanomoles of TBA reactive substance (TBARS) formed per
hour per gram of tissue using a molar extinction coefﬁcient
of 1.56 × 105 M−1 cm−1.
Reduced glutathione (GSH)
GSH content was determined by the method of Jollow et al.
(1974). Ten percent tissue homogenate was mixed with 4.0%
sulphosalicylic acid (w/v) in a 1:1 ratio (v/v). The samples
were incubated at 4◦C for 1 h. The assay mixture contained
0.1 mL of supernatant, 1.0 mM DTNB, and 0.1 M PB (pH
7.4). The yellow color developed was read immediately at
412 nm in a spectrophotometer (BioRad). The GSH con-
tent was calculated as nmol GSH mg−1 protein, using molar
extinction coefﬁcient of 1.36 × 103 M−1 cm−1.
Myeloperoxidase (MPO)
MPO was evaluated by the method of Bradley et al. (1982).
A total of 0.1 mL of tissue homogenate was added to
1.45 mL of o-dianisidine in 1 mL methyl alcohol, 98 mL
50 mM phosphate buffer (pH 6.0), and 1 mL of 0.05% H2O2
solution as a substrate for MPO enzyme. The change in ab-
sorbancewasmeasuredat460nmusingBioRadspectropho-
tometer.OneunitofMPOactivitywasdeﬁnedasthequantity
able to convert 1 μmol H2O2 per min at 25◦C and was ex-
pressed as unit per gram tissue.
TTC staining
A 1.5-mm-thick cross-section of spinal cord tissue was
rapidly cut after completion of hypoxia or hypoxia + treat-
ment in various groups. The sections were stained by incu-
batingtheminasolutionof2%of2,3,5-triphenyltetrazolium
chloride(TTC)at37±0.5◦Cfor15min.Forimaging,thesec-
tions were scanned by a high-resolution scanner (CanoScan-
LiDE25). The total mean infract area of each section was
measured.Infarctsizeofthedifferentgroupswasnormalized
to the sham and expressed as a percentage and an average
value from the four slices was presented.
Statistical analysis of data
Thestatisticalanalysisofdatawasdoneusinganalysisofvari-
ance (ANOVA) with post hoc analysis. The Tukey–Kramer
posthoctestwasappliedtoserveassigniﬁcantamonggroups.
The signiﬁcance of results was ascertained at P < 0.05. All
the data are presented as mean± SE (n = 6) of the means.
Results
ATP quantitation
Mitochondrial ATP content decreased signiﬁcantly (P <
0.001) in hypoxic group by 30.64% when compared with
sham group values. However, as a result of drugs treatment,
a signiﬁcant (P < 0.05–0.01) restoration was seen in ATP
level in the hypoxic groups treated with FK-506 (FK-506 +
Hypoxic) and CsA (CsA + Hypoxic) by 11.19% and 16.14%,
respectively, when compared to hypoxic group (Fig. 1).
Calcium uptake in mitochondria
Hypoxia/reperfusion resulted in signiﬁcant mitochondrial
swelling (P < 0.001) evident by a decrease in absorbance
(90.9%) in the hypoxic group (Fig. 2). It was observed that
FK-506 treatment at a concentration 0.1 μM caused a sig-
niﬁcant decrease (P < 0.05) in mitochondrial swelling in
the FK-506 + Hypoxia group. There was also a signiﬁcant
decrease (P < 0.05) in mitochondrial swelling with the
CsA-treated hypoxic group, as shown by 14.83% decrease
Figure 1. ATP content in various groups. Values are expressed as pmol
ATP per mg protein (mean± SE, n = 6). Signiﬁcant difference §P < 0.001
whencomparedwithsham;*P <0.05,**P <0.01whencomparedwith
hypoxic group. Hypoxia resulted in signiﬁcant decrease (P < 0.001) in
ATP content, which was signiﬁcantly increased (P < 0.05–0.01) by the
treatment of FK-506 and cyclosporine A (CsA) in hypoxic group. Both
the drugs showed same ATP-restoring effect. There was no difference
between both the groups.
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Figure 2. Calcium uptake in spinal cord mitochondria. Mitochondria
(25 mg/reaction) were deenergized via incubation in isotonic buffer at
room temperature for 3 min. After incubation, calcium (100 μM) was
added to the reaction mixture and absorbance was measured at 540
nm for 5 min at every 1-min time interval. Results are shown as percent
change in absorbance corresponding to the absorbance of deenergized
mitochondria.
in absorbance. When a comparison was made, FK-506 de-
creased mitochondrial swelling more efﬁciently than CsA
(Fig. 2).
Tissue LPO level
As a result of spinal hypoxia/reperfusion, a signiﬁcant in-
crease (P < 0.001) in LPO level was observed in the hypoxic
groupascomparedwithshamvalues.Drugtreatmentwithei-
therFK-506orCsAresultedinasigniﬁcant(P <0.01–0.001)
decrease in the level of LPO in the FK-506 + Hypoxia and
Figure 3. Rate of lipid peroxidation (LPO) in different groups. Values are
expressed as mean ± SE (n = 6). Signiﬁcant difference §P < 0.001 when
compared with sham; *P < 0.01, **P < 0.001 when compared with
hypoxic group. Hypoxia resulted in signiﬁcant increase (P < 0.001) in
LPO, which was signiﬁcantly decreased by the treatment of FK-506 and
CsA in hypoxic group. Both the drugs showed the same LPO-lowering
effect.
Figure 4. Reduced glutathione (GSH) content in various groups. Values
are expressed as mean ± SE (n = 6). Signiﬁcant difference §P < 0.001
when compared with sham; *P < 0.01 when compared with hypoxic
group. Hypoxia resulted in signiﬁcant decrease (P < 0.001) in GSH con-
tent, which was signiﬁcantly increased (P < 0.01) by the treatment of
FK-506 and CsA in hypoxic group. There is no difference between drugs
group.
CsA + Hypoxia groups when compared to hypoxic group
(Fig.3).Nosigniﬁcantdifferencewasobservedbetweenboth
the drug-treated groups.
Tissue GSH content
Spinal hypoxic damage signiﬁcantly (P < 0.001) depleted
the GSH content in mitochondria in the hypoxic group over
sham values (Fig. 4). As a result of FK-506 and CsA treat-
ment, a signiﬁcant (P < 0.01) restoration in mitochondrial
GSH content was seen in the FK-506 + Hypoxia and CsA +
Hypoxiagroupswhencomparedwiththehypoxicgroup.No
signiﬁcant difference was observed between both the drug-
treated groups.
Tissue MPO activity
Asigniﬁcant(P <0.001)increaseinMPOactivitywasseenin
the hypoxic group compared to sham values. It was observed
that treatment with either FK-506 (P < 0.001) or CsA (P <
0.01) caused a signiﬁcant decrease in MPO activity in the
FK-506 + Hypoxia and CsA + Hypoxia groups as compared
to the hypoxic group (Fig. 5). It was observed that FK-506
signiﬁcantly (P < 0.01) decreased MPO activity (42.86%)
than CsA (18.66%).
Tissue viability
TTC staining in sham did not show any detectable lesion
(Fig. 6). On the contrary, sections obtained from hypoxic
groupshoweddetectablelesionsaswhitepatches.Thelesions
were present in both white and gray matter. It was observed
that FK-506 and CsA treatment signiﬁcantly decreased the
lesions (P < 0.05) as compared to hypoxic group.
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Figure 5. Myeloperoxidase (MPO) activity in various groups. Values are
expressed as mean ± SE (n = 6). Signiﬁcant difference §P < 0.001 when
compared with sham; *P < 0.01, **P < 0.001 when compared with
hypoxic group and #P < 0.01 when a comparison was made between
both the drugs. Hypoxia resulted in signiﬁcant increase (P < 0.001) in
MPO activity, which was signiﬁcantly decreased by the treatment of FK-
506 and CsA in hypoxic group. FK-506 showed signiﬁcantly (P < 0.01)
more MPO lowering effect than CsA.
Discussion
The present study demonstrated that in vitro hy-
poxic/reperfusion spinal injury exacerbates myriad cascade
ofeventsinvolvingenergydepletion,mitochondrialswelling,
increased LPO with decrease in GSH levels, and increased
MPO level. Intervention with FK-506 and CsA restored the
depleted ATP stores, inhibition of mitochondrial swelling,
and decrease in oxidant indices with substantial restoration
ofendogenousGSH.Theseresultsconﬁrmthattheprotective
actionsofFK-506andCsAaremediatedviatheirantioxidant
actions.
Reactive oxygen species (ROS) generation is the key com-
ponent of the secondary neuronal damage in the spinal cord
andbraininjury(Hall1989;Aksenovaetal.2002).Thedisas-
trously increased ROS formed during spinal hypoxia attach
to membrane polyunsaturated fatty acids, thereby inﬂicting
LPO and also increasing membrane permeability because
the tissue is very sensitive and vulnerable (Lewen et al. 2000;
Yousuf et al. 2005, Atif et al. 2009). We observed a marked
increase in LPO level in hypoxic spinal cord that could be
attributedtotheROSaction.Undernormalconditions,ROS
are generated in the mitochondria, which are rapidly scav-
enged by the various enzymatic and nonenzymatic antiox-
idants. Reduced GSH is the primary line of defense against
ROS. GSH is consumed by glutathione peroxidase enzyme
during H2O2 elimination and therefore in an environment
where there is oxidative stress, intracellular GSH content is
depleted. GSH and other thiol-containing proteins are im-
portant in cellular defense against hypoxic damage. In the
Figure 6. Neuroprotective effect of FK-506
and CsA in spinal cord hypoxia. (A)
Representative photographs of spinal cord
sections stained with 2%
2,3,5-triphenyltetrazolium chloride (TTC).
White patches show the infraction. (B) Infract
(%) measurement in different groups. There is
signiﬁcant increase in infract size in hypoxic
group as compared to sham (P < 0.001).
Treatment of FK-506 and CsA signiﬁcantly
reduces the infract size (P < 0.05) as compared
to hypoxic group.
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present study, GSH content was found to be depleted in the
hypoxic group.
ROS-mediated oxidative damage participates in the exac-
erbation of intracellular calcium levels leading to mitochon-
drial swelling, which plays a critical role in several forms
of neuronal death (Coyle and Puttfarcken 1993; Choi 1995;
LeistandNicotera1998;Okabeetal.2000;Xiongetal.2007).
Mitochondrial swelling is an indicator of the opening of the
mitochondrial permeability transition pores (MPTP), which
resultsindepolarizationofmitochondrialmembranepoten-
tial. Our ﬁndings too demonstrated a signiﬁcant increase in
Ca2+-induced swelling in hypoxic mitochondria. Mitochon-
drial swelling subsequently results in altered oxidative phos-
phorylation, eventually affecting ATP production (Halestrap
2005). CNS has limited intrinsic energy reserves and re-
quires a constant supply of oxygen and nutrients. Energy
metabolism change or ATP depletion leads to depolarization
and failure of energy conduction. A signiﬁcant decrease in
ATP level in the hypoxic spinal cord as a result of 1-h spinal
hypoxiawasobservedinthisstudy.Therearevariousreports
that indicate that intracellular ATP production is the prime
target of hypoxia/ischemia-induced free radicals (Halestrap
2005).
In the present study, MPO activity was assessed for the
index of tissue oxidative load, which is considered as one of
the hallmark indicator of necrotic cell death (Erman et al.
2005).Weobservedthathypoxicspinalcordshowedincrease
in MPO activity. Neutrophil and microglia activation have
been shown responsible for increased MPO activity (Taoka
and Okajima 1998; Erman et al. 2005; Fleming et al. 2006)
during CNS injuries. In this in vitro model, since there is no
blood infusion, so the probable source of MPO is microglia
alone.
We used two neuroimmunophilins (FK-506 and CsA) to
understand their effects on spinal cord hypoxic injury in-
duced secondary neuronal damage in spinal cord. It was
observed that both FK-506 and CsA signiﬁcantly reduced
the level of LPO and MPO activity in the hypoxic group.
This could be due to the ability of FK-506 and CsA to in-
hibit microglia activation by inhibiting calcineurin, which
activates transcription factor NF-AT and thereby eventually
decreasing MPO and LPO level in the hypoxic spinal cord
(Taoka and Okajima 1998; Erman et al. 2005). However,
study by Mun and Ha (2010) has shown that CsA treatment
of glioma leads to increase ROS production and neurolog-
ical side effects. FK-506 has been reported to protect the
spinal cord by targeting microglia cells (Guzm´ an–Lenis et al.
2008) after excitotoxicity. CsA and FK-506 have been used
as an immunosuppressant in traumatic or ischemic CNS
damage and it was shown that these neuroprotectants in-
hibit microglia cells activation (Hailer 2008). FK-506 is also
reported to block NF-κB ,t u r n i n go f ft h eg e n eo fI C A M -
I, thereby limiting the inﬂammatory damage and infarct
size during ischemia/reperfusion (Squadrito et al. 2000).
Nishinaka et al. (1993) reported that FK-506 exerted a pro-
tection on ischemia/reperfusion-induced damage in canine
heart, which was suggested due to the ability of FK-506 to
reduce superoxide radical formation.
It was observed that FK-506 and CsA treatment signiﬁ-
cantly restored GSH content in the hypoxic groups. There
is a correlation between the level of LPO and GSH content;
both are inversely proportional to each other. The inversely
proportional LPO and GSH content could help explain the
mechanism by which FK-506 and CsA reduced peroxidative
membrane damage by inhibiting microglia activation and
thereby maintaining GSH content.
FK-506andCsAtreatmentmarkedlydecreasedmitochon-
drialswellinginhypoxicmitochondria.ATPcontentwasalso
foundtobeincreasedwithFK-506andCsA treatment.It has
beenreportedthatROSgenerationplaysacentralroleinalter-
ing mitochondrialmembraneintegrity,whichleads to open-
ing of MPTP and increased ion inﬂux, that is, calcium (Peng
and Jou 2004). MPTP opening results in uncoupling respira-
tionfromATPsynthesis,organelleswelling,disruptionofthe
outermembrane,andreleaseofdifferentapoptogenicfactors
into the cytosol (Green and Reed 1998; Kroemer et al. 1998).
IthasbeenreportedthatCsAbindstocyclophilinDandpre-
vents opening of mitochondrial transition pore (Mbye et al.
2008;Panickaretal.2009).However,theexactmechanismby
which FK-506 and CsA exert their ROS-scavenging potential
is not well understood yet.
Hypoxia results in tissue damage as observed by white
patches in gray and white matter. FK-506 and CsA treatment
showedsigniﬁcantreductionofwhitepatches,whichconfers
lesstissuedamageandincreaseviability.FK506was,however,
more effective over CsA in reducing white patches.
On the basis of the ﬁndings above, it could be speculated
that FK-506 and CsA inhibited ROS-mediated mitochon-
drial swelling and restored ATP synthesis, as evidenced by
the decrease in mitochondrial swelling and restoration of
ATP content and reduction in the tissue damage as observed
by TTC staining.
The present results suggested that ROS culminate in irre-
versible secondary damage in the spinal cord. Independent
treatment with FK-506 and CsA showed neuroprotective ef-
fectagainstROS-mediatedmitochondrialdysfunctions.Fur-
ther studies on combinatorial effect of CsA and FK-506 may
provideamoreeffectivestrategyinthemanagementofROS-
mediated secondary neuronal damage in spinal cord.
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